News and Publications

Penningtons Manches Cooper advises on medtech funding round

Posted: 22/04/2021


The corporate team at Penningtons Manches Cooper has acted for Oxford-based Caristo Diagnostics in a multimillion-pound investment round. The round was led by BGF and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).

Caristo is committed to transforming health outcomes through clinical and scientific innovation. The funding will be used to roll-out Caristo’s CaRi-Heart®, a first-of-its-kind technology that has the power to detect ‘invisible’ risk in people with possible heart disease by using routine heart scans. CaRi-Heart® recently received its CE mark accreditation, meaning it can be rolled out across the UK and Europe.

Penningtons Manches Cooper has acted for Caristo since its spin-out from the University of Oxford in 2018. The team was led by partner James Went and senior associate Attilio Leccisotti.


Return to news headlines

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority.

Penningtons Manches Cooper LLP